A Yale-led research team developed a new RNA therapy, delivered through the nose, to treat mice infected with West Nile Virus. The innovative approach reduced the virus in the brain, allowing the immune system to destroy the virus and develop long-term protection against West Nile Virus disease, the researchers said.
The findings, published in Cell Host & Microbe, may represent a breakthrough strategy for treating West Nile Virus after virus invasion of the brain and the central nervous system, noted senior author Priti Kumar, M.D., associate professor of infectious disease at Yale School of Medicine.
There are no approved vaccines or effective therapies for West Nile Virus disease, a mosquito-borne condition. While many infected individuals have no symptoms, others — particularly the very young and older adults — can develop severe neurological problems and even die from the disease. The sporadic nature of the disease makes it exceedingly difficult for testing and implementing vaccines, said Kumar.
To investigate a possible new therapy to treat West Nile Virus disease, Kumar and her colleagues focused on a small “interfering” RNA molecule developed in her lab. The RNA acts against multiple mosquito-borne flaviviruses. To direct the RNA to infected cells, they packaged it in a peptide derived from the rabies virus, which is able to enter nerve cells. The final step was to the deliver the therapy through the nose where it could bypass natural barriers protecting the brain.
With this novel approach, the researchers found that the therapy reduced the virus in the brain, preventing harm to nerve cells. The treated mice had a 90% survival rate a few days after infection compared to mice treated with placebo. Significantly, noted the researchers, in the surviving mice, the immune system cleared the virus throughout the body, and also enabled long-term protection against future exposure.
The researchers concluded that the treatment offers both a promising late-stage therapy and lifelong immunity. It “prevents pathology in the brain and gives the mice a chance to develop a robust immune response,” said Kumar.
While the anatomy of the murine nose differs from that of humans, the researchers plan to study the therapy further with the hope it will be broadly applicable. “In translation, it should be an effective strategy for people,” she said.
If that is the case, the intranasal RNA therapy could theoretically be developed for treatment of other mosquito-borne diseases, such as St. Louis encephalitis, Japanese encephalitis, and perhaps Zika, the researchers noted.
The Latest on: RNA therapy
via Google News
The Latest on: RNA therapy
Pfizer Initiates Pivotal Phase 3 Program for Investigational Hemophilia B Gene Therapy
on July 17, 2018 at 12:45 am
Phase 3 lead-in study initiated following completion of the transfer of Spark Therapeutics’ hemophilia B gene therapy program to Pfizer NEW YORK, NY & PHILADELPHIA, PA, USA I July 16, 2018 I Pfizer In... […]
Finding The Best Match: RNA Sequencing for Cancer Therapy Decisions
on July 16, 2018 at 1:17 am
Finding the best therapy match for a tumor is a challenge—not only because there are so many treatment options to choose from, but also because of the high complexity of tumor biology. Sequencing tech... […]
Cytori Reports Sustained Benefit of Cell Therapy in Erectile Dysfunction Trial
on July 10, 2018 at 2:07 am
The trial of Adipose-Derived Regenerative Cells (ADRCs) or Cytori Cell Therapy™ in erectile dysfunction (ED) following radical prostatectomy was performed by investigators from the Danish Centre for R... […]
Researchers develop a novel RNA-based therapy to target West Nile virus
on March 29, 2018 at 9:03 am
A Yale-led research team developed a new RNA therapy, delivered through the nose, to treat mice infected with West Nile Virus. The innovative approach reduced the virus in the brain, allowing the immu... […]
Researchers invent novel RNA nanotech to decorate exosomes for effective cancer therapy
on December 11, 2017 at 1:42 pm
A new study shows that attaching antibody-like RNA nanoparticles to microvesicles can deliver effective RNA therapeutics such as small interfering RNA (siRNA) specifically to cancer cells. Researchers ... […]
Podcast: Ceres’s close-up, how dogs listen, and a new RNA therapy
on September 1, 2016 at 11:20 am
News stories on what words dogs know, an RNA therapy for psoriasis, and how Lucy may have fallen from the sky, with Catherine Matacic. From the magazine In early 2015, NASA’s Dawn spacecraft entered o... […]
Spherical RNA therapy shows promise against psoriasis in first human trial
on August 29, 2016 at 2:42 pm
PHILADELPHIA, PENNSYLVANIA—RNA therapies have struggled for decades to meet expectations in fighting genetic diseases. Now, a new version, known as a spherical nucleic acid (SNA), has the field spring... […]
RNA combination therapy for lung cancer offers promise for personalized medicine
on August 15, 2014 at 5:00 am
The lung-targeting nanoparticle 7C1 delivers therapeutic RNAs to cancer cells: siRNA, labeled in red, inundates mutant lung-cancer cells, the nuclei of which are shown in blue, after 7C1-mediated tran... […]
RNA Combination Therapy for Lung Cancer Offers Promise for Personalized Medicine
on August 14, 2014 at 10:55 am
Source Newsroom: Koch Institute for Integrative Cancer Research at MIT Newswise — Small RNA molecules, including microRNAs (miRNAs) and small interfering RNAs (siRNAs), offer tremendous potential for ... […]
via Bing News